Navigation Links
New red blood cell simulator invented at Queen Mary
Date:6/28/2013

Engineers from Queen Mary, University of London have developed the world's most precise computer simulation of how red blood cells might travel around the body to help doctors treat people with serious circulatory problems.

Red blood cells have the important task of carrying oxygen around the body but make up less than half of the total blood volume 45 per cent in men and 40 per cent in women.

Understanding how damaged red blood cells might interact with each other or their neighbouring cells could be useful in realising blood flow in patients who are diabetic or have had surgery to address circulation complications, such as stents or artificial hearts.

The simulations, the largest of their kind, take into account the many forces acting on red blood cells as they travel through the blood vessels, which affect how the cells interact and stick to each other. The data gathered for the various flow situations in the simulation match the data gathered from experiments very closely.

John Williams, Professor of Computational Fluid Dynamics at the School of Engineering and Materials Science, said: "At the moment it's difficult to visualise how red blood cells travel through the body as they are very small and hard to track through enclosed vessels such as arteries and the heart. Our research will help medical professionals to visualise the cells movement, interaction, deformation and adhesion in three dimensions.

"This could help doctors in understanding which areas of the body are being starved of oxygen in patients who have had heart surgery, for example."

Professor Williams added: "Because of the enormous number of cells involved, we need vast supercomputer resources now in order to carry out a simulation of the flow of both damaged and undamaged red blood cells through a stent to study the effects on the cells."

The research is published in the Journal of Biomechanics.


'/>"/>

Contact: Neha Okhandiar
n.okhandiar@qmul.ac.uk
020-788-27927
Queen Mary, University of London
Source:Eurekalert

Page: 1

Related biology technology :

1. China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013
2. China Cord Blood Corporation to Report Fourth Quarter and Full Year of Fiscal 2013 Financial Results
3. Cellular Therapy and Cord Blood 2013 Market Report
4. Alzheimers Leaves Clues in Blood
5. Novartis highlights new findings in advancing care for patients with 170 abstracts in breast, lung and blood cancers at ASCO and EHA
6. Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science
7. New York Blood Centers Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development
8. BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute
9. Lisa Lorraine Reyes Muñoz, GeneCell International’s Physician Relation's Manager Launches Educational Meetings for General Public on Umbilical Cord Blood Stem Cells
10. A Blood Sample Predicts if Cancer Patients Respond to Therapy
11. Save The Cord Foundation, a Global Leader in Cord Blood Advocacy, Announces its Expansion of Educational Information Surrounding Other Non-Controversial Stem Cell Sources
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... -- Liquid Biotech USA , Inc. ... Research Agreement with The University of Pennsylvania ("PENN") ... patients.  The funding will be used to assess ... outcomes in cancer patients undergoing a variety of ... to support the design of a therapeutic, decision-making ...
(Date:6/24/2016)... , ... June 24, 2016 , ... While the majority ... as the Cary 5000 and the 6000i models are higher end machines that use ... height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... MA (PRWEB) , ... June 23, 2016 , ... ... Peel Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute ... platform of microbial tests introduced last year,” stated Bob Salter, Vice President of ...
Breaking Biology Technology:
(Date:6/22/2016)... ANGELES , June 22, 2016 /PRNewswire/ ... identity management and verification solutions, has partnered ... edge software solutions for Visitor Management, Self-Service ... provides products that add functional enhancements ... partnership provides corporations and venues with an ...
(Date:6/16/2016)... , June 16, 2016 ... size is expected to reach USD 1.83 billion ... Grand View Research, Inc. Technological proliferation and increasing ... applications are expected to drive the market growth. ... , The development of advanced multimodal ...
(Date:6/7/2016)...  Syngrafii Inc. and San Antonio Credit Union ... integrating Syngrafii,s patented LongPen™ eSignature "Wet" solution into ... result in greater convenience for SACU members and ... existing document workflow and compliance requirements. ... Highlights: ...
Breaking Biology News(10 mins):